SCHEMBL2365814

SCHEMBL2365814

ON1CCc2ccc(Cl)cc2CC1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 2/20 0.53
▸ HTR2C P28335 2/20 0.53
▸ HTR2B P41595 2/20 0.53
▸ NOTUM Q6P988 2/20 0.46
▸ PNMT P11086 1/20 0.46
▸ DRD2 P14416 3/20 0.40
▸ DRD1 P21728 3/20 0.40
▸ DRD5 P21918 3/20 0.40
▸ DRD3 P35462 3/20 0.40
▸ AKR1C3 P42330 2/20 0.40
▸ AKR1C1 Q04828 1/20 0.40
▸ DRD4 P21917 2/20 0.40
▸ SRD5A1 P18405 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ HSD17B3 P37058 2/20 0.38
▸ ACACB O00763 1/20 0.37
▸ TAS1R3 Q7RTX0 1/20 0.37
▸ TAS1R1 Q7RTX1 1/20 0.37
▸ TAS1R2 Q8TE23 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL160943 0.81 HTR2A (0.55) HTR2AHTR2CHTR2BNOTUMPNMT
SCHEMBL15962624 0.79 — —
Ammonia Solution, Strong SCHEMBL10465265 0.77 HTR2A (0.67) HTR2AHTR2CHTR2BPNMTSRD5A1
SCHEMBL6883015 0.76 MAOA (0.59) HTR2AHTR2CHTR2BDRD2DRD1
SCHEMBL11068898 0.76 NOTUM (0.59) NOTUMHSD17B3
SCHEMBL5221227 0.75 HTR2A (0.64) HTR2AHTR2CHTR2BPNMTHTT
SCHEMBL29724224 0.75 HTR2A (0.64) HTR2AHTR2CHTR2BPNMTHTT
SCHEMBL30218134 0.75 HTR2A (0.64) HTR2AHTR2CHTR2BPNMTHTT
SCHEMBL5496769 0.75 HTR2A (0.64) HTR2AHTR2CHTR2BPNMTHTT
SCHEMBL1905997 0.75 DRD2 (0.58) HTR2AHTR2CHTR2BNOTUMPNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2363394-A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders Arena Pharmaceuticals, Inc. (US) 2011-09-07 — — EP disclosed
Send feedback